The role of GTP on somatostatin-induced K+ current increase was examined in dissociated human pituitary tumor cells obtained from three acromegalic patients. Pituitary cells in culture were voltage-clamped by using the patch clamp technique in the whole-cell configuration. Somatostatin (100 nM) increased the membrane permeability to K+ ions and inhibited hormone secretion. A current-voltage relation of the somatostatin-induced K+ current showed an inward rectification when the concentration of extracellular K+ ions was increased. 
technique in the whole-cell configuration. Somatostatin (100 nM) increased the membrane permeability to K+ ions and inhibited hormone secretion. A current-voltage relation of the somatostatin-induced K+ current showed an inward rectification when the concentration of extracellular K+ ions was increased. The amplitude of the somatostatin-induced K+ current decreased during recording when the patch pipette solution did not contain GTP; addition of 100 FAM GTP to the patch pipette solution prevented this reduction. Intracellular application of 100 FAM guanosine 5'-[r-thio]triphosphate (GTP[vS] evoked an inward rectifying jK( conductance in the absence of somatostatin. After the GTP vS]-induced K conductance reached a steady level, application ofsomatostatin did not further increase the K+ conductance. In pertussis toxin-treated cells GTP [ S] did not evoke K+ conductance. It was concluded that somatostatin-induced K+ channels were regulated by a GTP-binding protein.
Somatostatin is a known inhibitory hormone in various tissues (1) . One of its modes of action has been attributed to be a reduction of intracellular Ca2" ions (2) . In previous papers (3, 4) we reported that in human growth hormone (GH)-producing cells, somatostatin increased the membrane permeability to K+ ions, thereby hyperpolarizing the membrane. This membrane hyperpolarization was associated with an inhibition of Ca2+-dependent spontaneous action potentials. This phenomenon accounts for the reduction of the intracellular Ca2+ concentration by somatostatin. We also reported that the pertussis toxin treatment selectively inhibited the somatostatin-induced K+ conductance, indicating that somatostatin-induced K+ channels are coupled to the inhibitory guanine nucleotide-binding protein (Gi protein) or the guanine nucleotide-binding protein of unknown function (G. protein) (4) . In the present study we examined the effect of intracellular GTP on somatostatin-induced K+ channels in human GH-producing cells to further clarify the involvement of the GTP-binding protein in somatostatin-induced K+ channels.
MATERIALS AND METHODS Cell Culture. GH-producing pituitary adenomas were obtained from three acromegalic patients during transsphenoidal surgery. The methods for preparing monolayer cell culture were essentially the same as described (3, 4) . The cells (-2 x 10 cells per ml) were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10o heatinactivated fetal calf serum. Hormone release assays were carried out within 10 days after cell preparation and electrophysiological studies were done within 1 month. 'The basal hormone secretion of the monolayered cells was as follows: the mean GH secretion was 213 ng/ml per 2 hr in adenoma 1, 37.2 ng/ml per 2 hr in adenoma 2, and 36.5 ng/ml per 2 hr in adenoma 3. The mean prolactin (PRL) secretion was 69.3 ng/ml per 2 hr in adenoma 3 and was undetectable in adenomas 1 and 2. According to immunohistochemical and hormone-release studies (5, 6) , most cells in adenomas 1 and 2 were considered to be GH-producing cells and a small amount of PRL-secreting cells may have existed in adenoma 3 in addition to GH-secreting cells. A more positive identification of GH-producing cells has been described elsewhere by using the reverse-hemolytic plaque assay (7) . Electrophysiological Analysis. For electrophysiological studies, a whole-cell variation of the patch electrode voltage clamp technique (8) (9) . The details of the above methods have been described elsewhere (3, 4) . The experiments were carried out at room temperature (20-250C) .
In previous studies (3, 4) somatostatin was applied near the recording cell through a glass capillary by using gas pressure, and somatostatin-induced responses were recorded usually within a few minutes after the formation of the whole-cell clamp condition. The maximum response was observed with 100 nM somatostatin (4) . In the present experiments, somatostatin (100 nM) was applied to the recording cells by perfusing the extracellular medium with a peristaltic pump, within a few minutes after the formation of the whole-cell clamp configuration. The pertussis toxin treatment was carried out by incubating the cells with pertussis toxin at 100 ng/ml for >24 hr. This treatment abolished somatostatininduced responses as shown in our previous study (4 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
vine serum albumin and incubated with the same medium containing 100 nM somatostatin. After the incubation for 2 hr, the medium was aspirated and centrifuged at 180 x g for 5 min. GH and PRL in the supernatant were assayed by double-antibody RIA (a kit supplied by S. Raiti of the National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases). Data are expressed as mean + SEM and statistical differences among data were tested by using Student's t test.
A 6K control -80 r RESULTS Somatostatin-Induced Membrane Current. As described previously (3, 4) , somatostatin-induced responses were consistently observed in three adenomas used in the present study (21/21 in adenoma 1, 22/24 in adenoma 2, 16/16 in adenoma 3). Fig. 1 A and B show the effect of somatostatin on membrane current during recording in the standard medium ( Fig. 1A ) and in 40 mM K+ (Fig. 1B) medium. The patch pipette contained 100 AM GTP (see below). Control currents were recorded before application of somatostatin and test currents were recorded 1-3 min after a continuous application of somatostatin. The membrane current became noisier after application of somatostatin, especially when the membrane voltage was clamped at a more negative potential. The control current was subtracted from the current record during the somatostatin application. The difference indicates the amplitude of the somatostatin-induced current and is plotted against the membrane potential in Fig. 1C , in which data obtained in 20 mM K+ medium are also shown. The intercept of the I-V relation at the abscissa indicates the reversal potential of somatostatin-induced currents. It was -80 mV in the standard medium, -51 mV in 20 mM K+ medium, and -32 mV in 40 mM K+ medium. The mean reversal potentials (mean + SD) of somatostatin-induced currents were -80.1 + 3.2 mV in the standard medium (n = 11), -51.5 + 1.9 mV in 20 mM K+ medium (n = 4), and -33.9 + 2.4mVin40mMK+ medium(n = 7), respectively. These values were close to the equilibrium potentials of K + ions expected from the Nernst equation. This observation confirmed our previous results that somatostatin increased the membrane permeability to K+ ions (3, 4) . The I-V relation of the somatostatin-induced K+ current showed an inward-going rectification in high K + media. Although the I-V relation in the standard medium for the cell in Fig. 1C was approximately linear, the I-V relation of other cells sometimes showed an inward-going rectification in the standard medium.
Rundown of the Somatostatin-Induced K ' Current. Fig. 2A shows changes of the membrane current during a 10-min recording after an application of somatostatin in the absence of GTP in the patch pipette solution. The extracellular medium was 40 mM K + medium. The holding potential was -35 mV and the test potential was -95 mV. Somatostatin was applied 2.5 min after the formation of the whole-cell clamp condition. Application of somatostatin initially increased the amplitude of the membrane current from -25 pA to -250 pA. During recording the amplitude of the membrane current decreased and at 10 min after exposure to somatostatin the amplitude of the inward current decreased to -80 pA. Fig. 2C shows the change of I-V relations obtained in another cell. Three I-V curves are shown: the control I-V relation, which was obtained within 2 min after the formation of the whole-cell clamp condition; the I-V relation recorded 0.5-1.5 min after somatostatin application; the membrane current recorded 10-12 min after somatostatin application. The three I-V curves crossed at -32 mV (arrow in Fig. 2C similar reduction of ionic currents during recording under the whole-cell clamp condition has been reported for voltagegated Ca2+ channels in snail neurons (10) and chromaffin cells (11) . This phenomenon (rundown or washout of Ca2" channel current) has been ascribed to the dependency of the channel activity on a substrate that diffuses out of the cell in the whole-cell clamp condition. Because in the previous study we found that the somatostatin-induced K+ current was sensitive to pertussis toxin (4), we considered that the rundown of the somatostatin-induced K+ current was due to a dilution of intracellular GTP under the whole-cell clamp condition. In fact, addition of 100 uM GTP in the patch pipette solution prevented the rundown of the somatostatin- somatostatin-induced K+ current showed an inward-going rectification, especially when the concentration of extracellular K + ions was raised. Because we showed in the previous study (4) that somatostatin-induced K + current was sensitive to pertussis toxin, it was concluded that somatostatin receptors couple to K+ channels by way of the GTP-binding protein. One may think that intracellular application of GTP prevented the desensitization of somatostatin. In the previous papers (3, 4) membrane currents were recorded without GTP in the patch electrode and somatostatin (100 nM-1 MM) was applied by pressure ejection within a few minutes after formation of the whole-cell clamp condition. Repetitive application of somatostatin evoked similar responses and therefore it seems unlikely that GTP prevented the desensitization, although this possibility cannot be entirely excluded. In submucous plexus neurons of guinea pig it has recently been reported that somatostatin increases an inward rectifying K+ conductance (12) . In rat GH3 cells somatostatin evokes a K + conductance by way of the GTP-binding protein, although the concentration of somatostatin in this preparation is very high (100-500 AM) (13 In atrial cells it has been reported that muscarinic agonist activates a type of K+ channel coupled to the GTP-binding protein (14) (15) (16) (17) . Somatostatin-induced K + channels possess similar characteristics to those of muscarinic agonist-induced K + channels, such as the inward rectifying I-V relation, the sensitivity to pertussis toxin, and the requirement of intracellular GTP. In the abdominal ganglion ofAplysia it has been shown that dopamine, histamine, and acetylcholine receptors are coupled to K+ channels through a single GTP-binding protein (18 latter report that the G. protein isolated from bovine brain was much less effective in activating K + channels than the G, from human erythrocytes.
In neuroblastoma-glioma hybrid cells it was reported that the a-subunit of the G. protein decreased voltage-gated Ca2 + channel current (19) . In clonal pituitary AtT-20 cells somatostatin reduces voltage-gated Ca2+ channel current through activation of the GTP-binding protein (20) . Similarly, an inhibition of voltage-gated Ca2+ channel current by somatostatin has been reported in neuroblastoma-glioma hybrid NG108-15 cells (21) . In rat sensory neurons voltage-gated Ca2+ channels are modulated by guanine nucleotides (22) , although the effects of guanine nucleotides in this report appear to be more complex than those in AtT-20 cells and NG108-15 cells. Considering these reports it is plausible that the G, protein [or the Gk protein termed by Yatani et al. (17) ] is coupled to K+ channels and the G. protein is coupled to voltage-gated Ca2+ channels. This notion may explain the different modes of somatostatin action reported in other cells (20, 21) .
